ArticleBMC infectious diseases2022

Effectiveness and safety of bedaquiline-containing regimens for treatment on patients with refractory RR/MDR/XDR-tuberculosis: a retrospective cohort study in East China.

Shao-Jun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.